Engineered Latent Guide RNAs for LRRK2 RNA Editing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current technologies lack an effective method for specifically editing adenosine in LRRK2 RNA, which is crucial for treating diseases associated with mutations in the LRRK2 polypeptide.

Innovation Solution

Engineered latent guide RNAs that, upon hybridization to LRRK2 RNA, form guide-target RNA scaffolds with specific structural features like mismatches, bulges, internal loops, and hairpins, facilitating targeted RNA editing by RNA editing entities such as ADAR1 and ADAR2.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional guide RNAs are used for RNA editing, then the editing process can proceed, but the specificity and efficiency of adenosine editing in LRRK2 RNA is insufficient

Engineering Contradiction:
Improveediting specificityVSAvoidediting efficiency
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The guide RNA is engineered with specific local structural features including a mismatch at position +1 relative to the target adenosine, and internal loops at positions -14 to -16 and +22 to +24. These localized structural modifications create a unique micro-footprint that significantly enhances both the specificity and efficiency of adenosine editing in LRRK2 RNA without affecting other regions of the RNA molecule.

Inventive Principle:
Principle #3Local quality

2Stability of the object's composition

If the guide RNA sequence is highly complementary to the target RNA, then hybridization stability increases, but the formation of specific structural features like mismatches and internal loops becomes difficult

Engineering Contradiction:
Improvehybridization stabilityVSAvoidstructural feature formation
Core Design Contradiction:
Stability of the object's compositionVSManufacturing precision

Solution Approach 1:

The guide RNA is pre-engineered with predetermined mismatch and internal loop positions in its sequence design. These structural features are built into the guide RNA molecule before hybridization occurs, ensuring that upon binding to the target LRRK2 RNA, the specific micro-footprint structure forms automatically. This preliminary structuring resolves the conflict between hybridization stability and structural feature formation.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The engineered guide RNAs achieve high specificity and efficiency in editing the target adenosine in LRRK2 RNA, potentially leading to therapeutic interventions for diseases like Parkinson's and Crohn's.

Implementation Method 1

upon hybridization to a sequence of a target LRRK2 RNA, forms a guide-target RNA scaffold

Methodology Applied
Scientific EffectHybridization:

Implementation Method 2

facilitates RNA editing of an on-target adenosine in the sequence of the target LRRK2 RNA by an RNA editing entity

Methodology Applied
Scientific EffectRNA editing: Enzyme

Data Source

PatentUS20250066774A1Engineered Guide RNAs and Polynucleotides
Publication Date: 2025.02.27 SHAPE THERAPEUTICS INC
  • US20250066774A1 patent drawing
  • US20250066774A1 patent drawing
  • US20250066774A1 patent drawing

AI summary

Disclosed herein are engineered latent guide RNAs targeting LRRK2 and compositions comprising the same for treatment of diseases or conditions (e.g. Parkinson's Disease) in a subject. Also disclosed herein are methods of treating diseases or conditions (e.g. Parkinson's Disease) in a subject by administering engineered latent guide RNAs or pharmaceutical compositions described herein.